Sanofi-aventis, a global healthcare leader, reported 2008 full-year earnings. Newly appointed CEO Chris Viehbacher comments on 2008 takeaways, portfolio review, diversification strategy, acquisitions and outlook for 2009.
Use these links to watch the video interview in the format of your choice:
Windows Media Player:
http://www.eurobusinessmedia.com/interviewWmp.php?id_article=405
Flash Player:
http://www.eurobusinessmedia.com/interviewFlash.php?id_article=405
Use this link to read the interview transcript:
http://www.eurobusinessmedia.com/transcript.php?id_article=405
Topics covered in the interview include:
- Takeaways from FY 2008
- Strengths of the company
- R&D pipeline review
- Productivity improvement
- Axes for diversification
- Acquisition strategy
- Financial flexibility
- Base business
- Emerging markets
- Ability to impove margins
- Guidance for 2009
- New appointments
- Vision for the company
About Sanofi-aventis:
Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT : SAN) and in New York (NYSE : SNY).
Company website: http://en.sanofi-aventis.com/home.asp
Sanofi-aventis
Investor Relations : IR@sanofi-aventis.com
Media
Relations : MR@sanofi-aventis.com
